Search Results
Found 1 results
510(k) Data Aggregation
(270 days)
HEALTHPIA AMERICA CORP.
The GlucoPack™ Diabetes Monitoring System is used for the quantitative measurement of glucose level in whole blood as an aid in monitoring the effectiveness of diabetes management in the home and in clinical settings. GlucoPack™ System is for testing outside the body (in vitro diagnostic use only). Testing sites include the traditional fingertips only.
The GlucoPack Diabetes Monitoring System is intended for use in the quantitative measurement of glucose in whole blood taken from the fingertip. Testing is done outside the body (in Vitro diagnostic use). It is indicated for use at home (over the counter (OTC)) by persons with diabetes mellitus, or in clinical settings by healthcare professionals, as an aid to monitor the effectiveness of diabetes control. It is not intended for use on neonates.
The GlucoPack™ Meter device is used along with the GlucoPack™ Test Strip to measure the glucose level in whole blood.
The provided document describes the GlucoPack™ Blood Glucose Test System (K052469) and its substantial equivalence to predicate devices, but it does not contain information about acceptance criteria, a study proving device performance against those criteria, or details regarding ground truth establishment, sample sizes for training/test sets, expert qualifications, or adjudication methods.
This 510(k) summary focuses on general device description, intended use, and comparison to predicate devices for substantial equivalence determination. Performance data, if present in the original submission, is not included in this extract.
Therefore, I cannot provide the requested information based on the given input. The requested details typically reside in the performance data section of a 510(k) submission, which is absent here.
Ask a specific question about this device
Page 1 of 1